Manel Esteller, elected member of the Academia Europaea

Manel Esteller.
Manel Esteller.
Research
(16/07/2021)

Manel Esteller, UB professor of Genetics at the Department of Physiological Sciences of the Faculty of Medicine and Health Sciences, has been elected member of the Academia Europaea in the Biochemistry and Molecular Biology Section.

Manel Esteller.
Manel Esteller.
Research
16/07/2021

Manel Esteller, UB professor of Genetics at the Department of Physiological Sciences of the Faculty of Medicine and Health Sciences, has been elected member of the Academia Europaea in the Biochemistry and Molecular Biology Section.

The institution, created in 1988, is the pan-European academy of sciences and arts. Its objective is the advancement and propagation of excellence in scholarship in humanities; law; economic, social and political sciences; mathematics; medicine, and all branches of natural and technological sciences of any part of the world, for public benefit and for the promotion of education on those topics for all ages. Its members, including 72 Nobel Prizes on different disciplines, are international leaders in their knowledge fields.

The council of Academia Europaea has chosen Esteller for his important contributions to biomedical sciences, and specifically for his discoveries in cancer epigenetics, which brought advances for the knowledge of this disease, the application of new diagnostic tests and the development of new treatments.

 

Manel Esteller i Badosa (Sant Boi de Llobregat, 1968) holds a doctorate on Medicine from the University of Barcelona. He was trained in the Vall dʼHebron Hospital Campus, in the Johns Hopkins Hospital (Baltimore, United States) and in the Spanish National Cancer Research Center (CNIO). He returned to Catalonia as the director of the Epigenetics and Cancer Biology program of the Bellvitge Biomedical Research Institute (IDIBELL). He is currently an ICREA researcher and leads the research line of Cancer Epigenetics in the Josep Carreras Leukaemia Research Institute. He has put epigenetics at the forefront of biomedicine.